Karyopharm Therapeutics reported $-49062000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2018M 429M
Abbvie ABBV:US $ 924M 3566M
Amgen AMGN:US $ 1317M 159M
AstraZeneca AZN:LN 29568.96M 177.38M
Astrazeneca AZN:US $ 360M 26M
Avrobio Inc AVRO:US $ -28054000 1.78M
Biocryst Pharmaceuticals BCRX:US $ -58.86M 15.34M
Bristol Myers Squibb BMY:US $ 1421M 143M
Eli Lilly And LLY:US $ 952.5M 950.4M
Enanta Pharmaceuticals ENTA:US $ -31.7M 1.89M
Epizyme EPZM:US $ -35.74M 19.76M
GlaxoSmithKline GSK:LN 83800M 96400M
Johnson & Johnson JNJ:US $ 4814M 335M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Macrogenics MGNX:US $ -41.3M 25.14M
Merk MRK:US $ 3944M 366M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Novartis NOVN:VX SF 1694M 528M
Novartis NVS:US $ 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Sangamo Biosciences SGMO:US $ -43.17M 0.8M
Takeda 4502:JP Y 105014M 116372M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
Xencor XNCR:US $ -33.98M 57.57M
YTE INCY:US $ 161.43M 123.44M